Conservatively managed unilateral MCKD
| Study | No. of children (antenatal diagnosis) | Follow up in years; mean (range) | No. of children with hypertension |
|---|---|---|---|
| Al Khaldi et al16 | 30 (30) | 0 | |
| Aubertin et al18 | 54 (54) | 0 | |
| Belk et al19 | 29 (29) | 0 | |
| Cigna et al20 | 16 (0) | 0 | |
| Ekoldt et al21 | 42 (42) | 3 (0.3–6) | 2 |
| Feldenberg et al22 | 28 (28) | 0 | |
| Gordon et al8 | 23 (23) | 0 | |
| John et al23 | 27 (27) | 4.9 (1–11.6) | 0 |
| Kaneyama et al24 | 30 | 5.3 | 0 |
| Kessler et al25 | 23 (18) | 0 | |
| Kuwertz-Broeking et al17 | 75 | 4 (1–11) | 1 |
| Martin et al26 | 15 | 0 | |
| Matsumoto et al27 | 44 (41) | 4.5 (1.4–9) | 0 |
| Miller et al28 | 75 | 4.4 | 0 |
| Okada et al29 | 10 (10) | 4 (1.5–100) | 0 |
| Oliveira et al9 | 20 (20) | 3 (0.5–8) | 0 |
| Orejas et al30 | 12 | 3 | 0 |
| Orikasa et al31 | 18 | (0.5–5) | 0 |
| Perez et al32 | 49 | 4 | 0 |
| Rabelo et al33 | 43 (43) | 4 (1–13) | 2 |
| Rickwood et al34 | 33 | 3 (1.2–6) | 0 |
| Ring et al35 | 6 (6) | (0.8–1.5) | 0 |
| Seeman et al36 | 18 (18) | 0 | |
| Sukthankar et al37 | 66 (66) | 5 | 0 |
| Tilemis et al14 | 20 (20) | (0.8–6) | 0 |
| Tohda et al38 | 14 (14) | 0 | |
| Vinocur et al10 | 19 (19) | 3 (0.2–9) | 1 |
| Wacksman et al12 | 260 (260) | 0 | |
| Ylinen et al39 | 16 | 4 | 0 |
| Total = 29 studies | 1115 (801) | 6 |